CA9 and neoplasm: This is consistent with a nonclinical evaluation of radiolabeled DPI-4452 in which sustained tumor retention (≤48 h after administration) of 111In-labeled-DPI-4452 in mice bearing CAIX-positive tumors was observed (15).